Standout Papers

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for in... 2000 2026 2008 2017 4.7k
  1. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial (2001)
    Michael P. Manns, John G. McHutchison et al. The Lancet
  2. Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis (2000)
    E. Jenny Heathcote, Mitchell L. Shiffman et al. New England Journal of Medicine
  3. Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1 (2012)
    Anna S. Lok, David Gardiner et al. New England Journal of Medicine

Immediate Impact

38 by Nobel laureates 13 from Science/Nature 128 standout
Sub-graph 1 of 13

Citing Papers

Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
1 intermediate paper

Works of Robert Reindollar being referenced

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout

Author Peers

Author Last Decade Papers Cites
Robert Reindollar 6534 5775 672 891 33 7.0k
Kenneth Koury 6175 5441 641 838 27 6.6k
Fernando Lopes Gonçales 5606 4892 558 745 41 6.0k
Amy Lin 5601 4905 604 713 23 6.5k
George Marinos 6836 6046 746 914 61 7.8k
Jian Yu 4784 4131 509 639 12 5.1k
Doris B. Strader 4896 5064 422 604 35 6.3k
M J Alter 5005 4518 321 798 55 6.0k
Robert P. Perrillo 8284 8768 617 1011 118 10.0k
Savino Bruno 5771 5547 402 622 132 6.9k
Vincent Thibault 5294 4875 727 1009 158 6.8k

All Works

Loading papers...

Rankless by CCL
2026